Torrent Pharmaceuticals

Quarterly
Consolidated
ParticularsSep '25Dec '25Mar '26Jun '26Sep '26
Revenue3,2753,2904,1804,9094,969
Expenses2,4712,4663,5854,1554,222
EBITDA1,0561,0751,3391,6521,656
EBIT839.00859.00765.001,0381,037
Profit Before Tax791.00814.00529.00733.00737.00
Net Profit591.00635.00364.00566.00534.00
Financial Ratios
Operating Profit Margin32.13%32.76%30.84%33.73%33.62%
Net Profit Margin18.49%19.75%9.91%11.99%11.03%
Earning Per Share (Diluted)17.4518.7711.5114.8714.05
Dividends Per Share0.0029.000.000.000.00